These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5791811)

  • 1. The contribution of citrate to the ferroxidase activity of serum.
    Lee GR; Nacht S; Christensen D; Hansen SP; Cartwright GE
    Proc Soc Exp Biol Med; 1969 Jul; 131(3):918-23. PubMed ID: 5791811
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification and purification of a non-ceruloplasmin ferroxidase of human serum.
    Topham RW; Frieden E
    J Biol Chem; 1970 Dec; 245(24):6698-705. PubMed ID: 4098342
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of citrate in abnormal copper metabolism.
    Nath R; Srivastava SK
    Metabolism; 1965 Dec; 14(12):1237-9. PubMed ID: 5845495
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of two procedures used for complexing Fe(III) with human apotransferrin: I. Physicochemical properties of the Fe(III) . transferrin products.
    Berry LR; Hatton MW
    Biochem Cell Biol; 1986 Sep; 64(9):936-45. PubMed ID: 3778666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of human serum ceruloplasmin by its p-phenylenediamine oxidase activity.
    Sunderman FW; Nomoto S
    Clin Chem; 1970 Nov; 16(11):903-10. PubMed ID: 5473551
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome.
    MARKOWITZ H; GUBLER CJ; MAHONEY JP; CARTWRIGHT GE; WINTROBE MM
    J Clin Invest; 1955 Oct; 34(10):1498-508. PubMed ID: 13263429
    [No Abstract]   [Full Text] [Related]  

  • 7. The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum.
    Osaki S; Johnson DA; Frieden E
    J Biol Chem; 1966 Jun; 241(12):2746-51. PubMed ID: 5912351
    [No Abstract]   [Full Text] [Related]  

  • 8. The mobilization of iron from the perfused mammalian liver by a serum copper enzyme, ferroxidase I.
    Osaki S; Johnson DA; Frieden E
    J Biol Chem; 1971 May; 246(9):3018-23. PubMed ID: 5554305
    [No Abstract]   [Full Text] [Related]  

  • 9. Ceruloplasmin, a link between copper and iron metabolism.
    Frieden E
    Ortop Travmatol Protez; 1969 Sep; 30(9):87-91. PubMed ID: 4910296
    [No Abstract]   [Full Text] [Related]  

  • 10. Kinetic studies of the Fe(II) oxidation with human serum ferroxidase-II.
    Topham RW; Johnson DA
    Arch Biochem Biophys; 1974 Feb; 160(2):647-54. PubMed ID: 4831632
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular pathology of ceruloplasmin.
    Neifakh SA; Vasilets IM; Shavlovskii MM
    Mol Biol; 1971; 5(6):739-42. PubMed ID: 5005463
    [No Abstract]   [Full Text] [Related]  

  • 12. [Isolation and characteristics of a protein similar to ceruloplasmin from the serum of a patient with hepatolenticular degeneration (Wilson-Konovalov disease)].
    Verbina IA; Puchkova LV
    Dokl Akad Nauk SSSR; 1985; 283(2):478-80. PubMed ID: 4042831
    [No Abstract]   [Full Text] [Related]  

  • 13. Further investigations on ceruloplasmin in hepatolenticular degeneration and on the effect of copper on oxidase activity of ceruloplasmin.
    Wald I; Galewicz A; Górska D
    Pol Med J; 1972; 11(3):733-9. PubMed ID: 5047986
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of ceruloplasmin (plasma ferroxidase) in hypoferremia associated with chronic inflammation and endotoxin.
    Roeser HP; Lee GR; Cartwright GE
    Proc Soc Exp Biol Med; 1973 Apr; 142(4):1155-8. PubMed ID: 4571821
    [No Abstract]   [Full Text] [Related]  

  • 15. Blood-reduced glutathione, pyruvic acid, citric acid, ceruloplasmin oxidase activity and certain mineral changes in diabetes mellitus before and after treatment.
    Awadallah R; El-Dessoukey EA; Doss H; Khalifa K
    Z Ernahrungswiss; 1978 Jun; 17(2):72-8. PubMed ID: 685321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated measurement of serum ferroxidase activity.
    Erel O
    Clin Chem; 1998 Nov; 44(11):2313-9. PubMed ID: 9799759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of the serum copper-oxidase activity in 8 families affected by Struempell-Wilson disease (hepatolentricular degeneration)].
    GIAGHEDDU M; CHESS-PERLE E
    Sist Nerv; 1961; 13():237-52. PubMed ID: 13898276
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum ferroxidase I and II in uremic patients under conservative treatment and maintenance hemodialysis.
    Frangos-Plemenos M; Agroyannis B; Koutsicos D; Tzanatos-Exarchou H; Logothetis E; Sarris E; Kaya S; Yatzidis H
    Int J Artif Organs; 1987 May; 10(3):195-8. PubMed ID: 3610372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of immunologic and enzymatic methods for ceruloplasmin quantitation in Wilson's disease.
    Rosenberg EB; Strickland GT; Feng YS; Blackwell RQ
    Taiwan Yi Xue Hui Za Zhi; 1971 Jan; 70(1):49-53. PubMed ID: 4996661
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum azide-resistant ferroxidase activity.
    Williams DM; Christensen DD; Lee GR; Cartwright GE
    Biochim Biophys Acta; 1974 May; 350(1):129-34. PubMed ID: 4407346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.